2,3-Dichloro-5-iodopyrazine

Catalog No.: 
ACJTMN347
CAS No.: 
1816294-11-7
Molecular Formula: 
C4HCl2IN2
Molecular Weight: 
274.88
2,3-Dichloro-5-iodopyrazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$103.00In stockIn stock
250mg97%$204.00In stockIn stock
1g97%$678.00In stockIn stock
5g97%$2530.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,3-Dichloro-5-iodopyrazine
IUPAC Name2,3-dichloro-5-iodopyrazine
MDL No.MFCD30573946
Molecular FormulaC4HCl2IN2
Molecular Weight274.88
SMILESIC1=CN=C(Cl)C(Cl)=N1
InChI KeyZJZLHUZOCHSRGQ-UHFFFAOYSA-N
Synonym2,3-Dichloro-5-iodopyrazine;Pyrazine, 2,3-dichloro-5-iodo-
CAS No.1816294-11-7
PubChem CID127258917

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACJTMN347 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNZKP851 route compound structure diagram
    ACNZKP851873-40-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJTMN347 route product structure diagram
    ACJTMN3471816294-11-7In Stock
Inquiry

2. ACJTMN347 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMVJO413 route compound structure diagram
    ACMVJO41359489-29-1In Stock
  4. Then
  5. ACJTMN347 route product structure diagram
    ACJTMN3471816294-11-7In Stock
Inquiry

3. ACJTMN347 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJTMN347 route product structure diagram
    ACJTMN3471816294-11-7In Stock
Inquiry

Comments (0)